Coherus Oncology (CHRS) Assets (2013 - 2026)
Coherus Oncology (CHRS) reported Assets of $191.18 million for Q2 2026, down 56.5% from $439.46 million a year earlier and down 28.1% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology posted Assets of $258.34 million, down 42.4% from FY2024.
- Assets has a five-year compound annual growth rate of -21.0% (FY2020 to FY2025).
- By year, Assets came in at $448.53 million in FY2024 (-28.8%), $629.6 million in FY2023 (+30.9%), $480.85 million in FY2022 (-29.2%) and $679.33 million in FY2021 (-19.3%).
- The Q2 2026 figure ranks as the lowest quarterly Assets since Q1 2019.
- Year over year, Assets has now declined in each of the last three quarters, with an average decline of 31.7% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q1 2024 (growth of 89.7%); the low point was Q2 2026 (a decline of 56.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $266.02 million (Q1 2026), $258.34 million (Q4 2025) and $516.52 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 191.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 191.18 Mn |
| Mar 31, 2026 | 266.02 Mn |
| Dec 31, 2025 | 258.34 Mn |
| Sep 30, 2025 | 516.52 Mn |
| Jun 30, 2025 | 439.46 Mn |
| Mar 31, 2025 | 371.07 Mn |
| Dec 31, 2024 | 448.53 Mn |
| Sep 30, 2024 | 505.00 Mn |
| Jun 30, 2024 | 674.86 Mn |
| Mar 31, 2024 | 763.55 Mn |
| Dec 31, 2023 | 629.60 Mn |
| Sep 30, 2023 | 583.78 Mn |
| Jun 30, 2023 | 469.59 Mn |
| Mar 31, 2023 | 402.43 Mn |
| Dec 31, 2022 | 480.85 Mn |
| Sep 30, 2022 | 550.91 Mn |
| Jun 30, 2022 | 546.00 Mn |
| Mar 31, 2022 | 593.39 Mn |
| Dec 31, 2021 | 679.33 Mn |
| Sep 30, 2021 | 741.73 Mn |
API Access
Coherus Oncology Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();